Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy
Main Authors: | Jia Wei, Zekai Mao, Na Wang, Lifang Huang, Yang Cao, Weimin Sun, Xiaolu Long, Jiaqi Tan, Chunrui Li, Yi Xiao, Chaojiang Gu, Shangkun Zhang, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.176 |
Similar Items
-
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
by: Chunrui Li, et al.
Published: (2021-03-01) -
Integrace procesů provozního oddělení společnosti DHL Express (Czech Republic) s.r.o.
by: Jumrová, Helena
Published: (2007) -
Bidirectional best hit <it>r</it>-window gene clusters
by: Leong Hon Wai, et al.
Published: (2010-01-01) -
Hantering av specialservice för DHL
by: Kedborg, Carina, et al.
Published: (2012) -
Processeffektivisering i DHL Supply Chain
by: Obeid, Qassim
Published: (2018)